Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Pocock

Showing results (61-70 of 245) with videos related to

Pageof 25
Sort By:
European Heart Journal. Acute Cardiovascular Care|March 12, 2020
Assessment of quality indicators for acute myocardial infarction management in 28 countries and use of composite quality indicators for benchmarkingXavier Rossello, Jesús Medina, Stuart Pocock, et al.
BMC Public Health|July 17, 2013
A cluster randomized trial to evaluate the efficacy of a school-based behavioral intervention for health promotion among children aged 3 to 5José L Peñalvo, Gloria Santos-Beneit, Mercedes Sotos-Prieto, et al.
Journal of the American College of Cardiology|March 21, 2015
Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage studyUsman Baber, Roxana Mehran, Samantha Sartori, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 18, 2018
Regional variations in hospital management and post-discharge mortality in patients with non-ST-segment elevation acute coronary syndromeHéctor Bueno, Xavier Rossello, Stuart Pocock, et al.
International Journal of Cardiology|July 29, 2017
Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortalityXavier Rosselló, Yong Huo, Stuart Pocock, et al.
European Journal of Heart Failure|October 4, 2022
Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR-ReducedGerasimos Filippatos, Stefan D Anker, Javed Butler, et al.
Journal of the American College of Cardiology|March 25, 2022
Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection FractionJoão Pedro Ferreira, Javed Butler, Faiez Zannad, et al.
JACC. Heart Failure|March 5, 2023
Recency of Heart Failure Hospitalization, Outcomes, and the Effect of Empagliflozin: An EMPEROR-Pooled AnalysisJoão Pedro Ferreira, Faiez Zannad, Javed Butler, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 4, 2019
Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rateKen Lee Chin, Timothy Collier, Stuart Pocock, et al.
European Journal of Heart Failure|December 2, 2017
Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failureEmil Wolsk, Brian Claggett, Lars Køber, et al.
Pageof 25

Showing results (61-70 of 245) with videos related to

Sort By:
Pageof 25
European Heart Journal. Acute Cardiovascular Care|March 12, 2020
Assessment of quality indicators for acute myocardial infarction management in 28 countries and use of composite quality indicators for benchmarkingXavier Rossello, Jesús Medina, Stuart Pocock, et al.
BMC Public Health|July 17, 2013
A cluster randomized trial to evaluate the efficacy of a school-based behavioral intervention for health promotion among children aged 3 to 5José L Peñalvo, Gloria Santos-Beneit, Mercedes Sotos-Prieto, et al.
Journal of the American College of Cardiology|March 21, 2015
Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage studyUsman Baber, Roxana Mehran, Samantha Sartori, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 18, 2018
Regional variations in hospital management and post-discharge mortality in patients with non-ST-segment elevation acute coronary syndromeHéctor Bueno, Xavier Rossello, Stuart Pocock, et al.
International Journal of Cardiology|July 29, 2017
Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortalityXavier Rosselló, Yong Huo, Stuart Pocock, et al.
European Journal of Heart Failure|October 4, 2022
Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR-ReducedGerasimos Filippatos, Stefan D Anker, Javed Butler, et al.
Journal of the American College of Cardiology|March 25, 2022
Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection FractionJoão Pedro Ferreira, Javed Butler, Faiez Zannad, et al.
JACC. Heart Failure|March 5, 2023
Recency of Heart Failure Hospitalization, Outcomes, and the Effect of Empagliflozin: An EMPEROR-Pooled AnalysisJoão Pedro Ferreira, Faiez Zannad, Javed Butler, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 4, 2019
Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rateKen Lee Chin, Timothy Collier, Stuart Pocock, et al.
European Journal of Heart Failure|December 2, 2017
Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failureEmil Wolsk, Brian Claggett, Lars Køber, et al.
Pageof 25